In a phase 1b placebo-controlled, randomized clinical trial, participants with overweight or obesity received OW SC cagrilintide at various doses or placebo, in conjunction with semaglutide 2.4 mg over 20 weeks [123]
As body composition changes, the volume of distribution for thyroid hormones may alter, potentially affecting serum levels
In preclinical research it is studied for its reported effects on tissue repair including tendon, ligament, muscle, and gut-lining models
The early data from obesity trials shows favorable trends in cardiovascular risk factors, but definitive outcome data remains forthcoming
Although not listed among common adverse reactions in FDA prescribing information, understanding potential causes and management strategies can help patients maintain treatment adherence while addressing this uncomfortable symptom
Enjoy both spot removal and travel in Bangkok